Follow the Ortoma AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Ortoma AB has recorded 8 public disclosures. Market capitalisation: €354.6m. The latest transaction was disclosed on 20 April 2026 (Purchase). Among the most active insiders: Roy Forslund. All data is free.
8
Insider Decl.
n/a
Thresholds
€488,784
7 ops.
Buy Volume
€21,412
1 ops.
Sell Volume
31Σ signal
Buys €488,784€21,412 Sells
Fundamental score
Ranked 22,064 of 29,063 companies
33.9
score / 100
Value
32
Quality
36
FCF yld0.9%
Earn yld-5.6%
EV/EBITDA·
ROE-37%
Gross mgn83%
Net mgn-30%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,632 shares@ SEK 24.90100.0% of flowAktieISINISIN SE0005676103FI:A001R050-1
8 of 8 declarations
Acerca de Ortoma AB
Ortoma AB es una empresa centrada en el sector de la salud y farmacéutico, dedicada al desarrollo de soluciones innovadoras para la cirugía ortopédica. Cotiza en la bolsa XSTO.